Fairvalue-Calculator Fairvalue-Calculator

Episil-Precision Inc (3016) Fair Value & Analysis

Technology · TW · Market cap 32.9B TWD

Price137.50 TWD
Fair Value145.40 TWD
Upside+5.7%
Quality95/100
Evidence: High Range 140.00 TWD – 151.12 TWD

Analysis

Episil-Precision Inc (3016) currently trades at 137.50 TWD, while our model-based Fair Value estimate is 145.40 TWD — implying the stock looks roughly 5.7% undervalued today. We read business quality at 95/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Episil-Precision Inc. engages in the development, manufacturing, and sale of silicon epitaxy wafers and compound semiconductor epitaxial wafers in Taiwan, Japan, China, and internationally. The company offers buried-layer epitaxy wafers, multi-layer epitaxy wafers, silicon epitaxy on SOI (silicon on insulator) wafers, GaN epitaxial wafers, and silicon carbide (SiC) epitaxial wafers for applications in high-power field effect transistors, diodes, and insulation; and power components, such as gate bipolar transistors (IGBTs) and power management ICs (PMICs). Its products are used in various industries comprising consumer electronics, automotive electronics, industrial control manufacturing, telecommunications, and computers. The company was incorporated in 1998 and is headquartered in Hsinchu City, Taiwan. Episil-Precision Inc. is a subsidiary of Episil Technologies Inc.

Open the full interactive analysis →

Similar stocks

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.